Showing results (1-10 of 317) with videos related to
Sort By:
Pageof 32
Hepato-Gastroenterology|February 26, 2000
Chronic inflammatory bowel disease and cancerC Pohl, A Hombach, W KruisZeitschrift Fur Gastroenterologie|February 24, 2001
[Aminosalicylates and aspirin for colonic cancer: from anti-inflammatory to antineoplastic drugs?]H Allgayer, T Tillmann, A Hombach, et al.Medizinische Klinik (Munich, Germany : 1983)|April 9, 1999
[Clinical effect of various 5-ASA preparations in ulcerative colitis]W Kruis, C PohlAnticancer Research|May 1, 1997
Activation of resting T cells against the CA 72-4 tumor antigen with an anti-CD3/CA 72-4 bispecific antibody in combination with a costimulatory anti-CD28 antibodyA Hombach, S Mathas, M Jensen, et al.Clinical and Experimental Immunology|May 1, 1997
Specific activation of resting T cells against tumour cells by bispecific antibodies and CD28-mediated costimulation is accompanied by Th1 differentiation and recruitment of MHC-independent cytotoxicityA Hombach, T Tillmann, M Jensen, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 23, 1997
Specific activation of resting T cells against CA19-9+ tumor cells by an anti-CD3/CA19-9 bispecific antibody in combination with a costimulatory anti-CD28 antibodyA Hombach, T Tillmann, M Jensen, et al.Gene Therapy|August 6, 1999
A chimeric receptor that selectively targets membrane-bound carcinoembryonic antigen (mCEA) in the presence of soluble CEAA Hombach, D Koch, R Sircar, et al.International Journal of Molecular Medicine|December 17, 1998
Chimeric anti-TAG72 receptors with immunoglobulin constant Fc domains and gamma or zeta signalling chainsA Hombach, R Sircar, C Heuser, et al.Gastroenterology|October 10, 1997
T cell targeting of TAG72+ tumor cells by a chimeric receptor with antibody-like specificity for a carbohydrate epitopeA Hombach, C Heuser, R Sircar, et al.Pageof 32